Carvana Plunges 18% on Short Report: A Tactical Mispricing or the Start of a Collapse?

The market's violent reaction today is a direct response to a high-conviction short report. Gotham City Research published its findings earlier in the day, and the stock has been in a freefall ever since. The core allegations are severe and specific. First, the report claims Carvana's 2023-2024 earnings are overstated by more than $1 billion. For context, that figure exceeds the company's total reported earnings for those two years, which were just over $550 million. Second, Gotham alleges the company's adjusted EBITDA is far more dependent on auto loan companies DriveTime and Bridgecrest than the market currently takes into account, with DriveTime's subsidies fueling over 73% of Carvana's earnings before interest and taxes. The report points to undisclosed related-party transactions and accounting irregularities as the mechanism.

The market's verdict has been swift and brutal. Carvana stock plunged 18.24% to $390.59 in the session. Shares are on pace for their worst single-day drop since October, and the damage extends beyond today. The stock is now down 14.32% over the past five days, a sharp reversal from a recent rally. This isn't just a minor correction; it's a collapse in sentiment triggered by a credible, detailed attack on the company's financial integrity. The setup is now a classic event-driven tension: a high-uncertainty catalyst has created a significant price dislocation. The question for tactical investors is whether this is a temporary mispricing or the start of a fundamental breakdown.

The Mechanics: Unpacking the Alleged Accounting and Dependency Engine

The Gotham report doesn't just allege fraud; it lays out a specific, leveraged engine that it claims powers Carvana's reported earnings. The core of this engine is a dependency on DriveTime, a company now under severe financial strain. According to the report, DriveTime burned over $1 billion in cash flow from operating activities from 2023 to 2024 while simultaneously taking on massive new debt. This has pushed its leverage to a staggering 20-40 times earnings, a level far above its historical cap of 10.3x. More critically, DriveTime's own adjusted EBITDA barely covered its interest expense, with a ratio of just 0.5x-1.0x. This creates a vulnerable foundation. The report argues that Carvana's own adjusted EBITDA is "far more dependent on" this struggling entity, and without its support, Carvana's earnings would collapse and its EBITDA wouldn't even cover its interest costs.

The alleged accounting loop that sustains this dependency is intricate. Gotham claims Carvana sells auto loans to so-called "third parties" at inflated rates, booking a gain on the sale. The twist is that the servicing of these loans is then handled by Bridgecrest, a company fully owned by Carvana's chairman and major shareholder, Ernie Garcia II. The report alleges that Bridgecrest charges these "third parties" a very low servicing fee of 0.117% per year. This creates a potential subsidy mechanism: Carvana books a profit on the sale, and the same related party (Bridgecrest) then collects a minimal fee on the loans it helps finance, effectively funneling value back into the Garcia-controlled ecosystem.

The predicted fallout from this alleged setup is severe. Gotham forecasts a cascade of corporate actions: Carvana's 2025 10-K will be delayed, its 2023 and 2024 10-Ks will need to be restated, and auditor Grant Thornton will resign. The plausibility of this dependency engine collapsing hinges on the financial health of DriveTime. If its leverage and cash burn are as severe as alleged, its ability and willingness to continue providing the credit support Gotham claims is critical to Carvana's earnings will inevitably come into question. The market's violent reaction suggests investors are now pricing in that risk.

The Counterweight: Earnings Catalyst and Valuation Context

While the short report has dominated the narrative, a near-term catalyst from the bullish camp is set to clash with this turmoil. JPMorgan maintains a confident stance, raising its price target to $510 and keeping an 'Overweight' rating. The firm's Q4 earnings preview explicitly expects Carvana to report a "solid beat and raise", citing strong unit growth assumptions. This forecast is due in just over a week, with the company scheduled to report fourth-quarter earnings on Feb. 18. This creates a clear event-driven tension: the market is pricing in severe accounting and dependency risks, while a major analyst is looking for a positive surprise on the top and bottom lines.

The valuation context, however, suggests the market had already priced in a robust growth story before this event. Despite the sharp plunge, Carvana trades at a premium. The stock's price-to-sales ratio (PS TTM) is 4.65, and its enterprise value to EBITDA (EV/EBITDA TTM) sits at 49.5. These multiples imply significant future growth expectations are still baked into the share price. The market's reaction to the short report is a direct challenge to those expectations, forcing a re-evaluation of the company's fundamental profitability.

This sets up a high-stakes test. The stock's year-to-date performance tells the story of the prior optimism: shares are up 65.99% over the past year. The recent 18% drop is a violent correction of that trend, but the valuation still reflects a company that must deliver on its growth promise. The upcoming earnings report is the immediate catalyst that could either validate the bullish thesis and spark a reversal, or confirm the short's dire warnings and accelerate the decline. For tactical investors, the event is clear: the market is choosing between two conflicting narratives, and the February 18 print will be the first concrete data point to resolve the tension.

Technical Levels and Risk/Reward Setup

The technical picture confirms the market's shift from a bullish trend to a state of acute uncertainty. Carvana is now trading decisively below its key moving averages, signaling a breakdown in short-term momentum. The stock sits well below its 50-day simple moving average (SMA) at ~$410 and its 200-day SMA at ~$430. These levels, which were once support, are now acting as dynamic resistance. A break below the 50-day SMA, which occurred earlier this week, is a classic bearish signal, often prompting algorithmic and momentum traders to sell.

The full range of volatility is stark. The stock's 52-week high is $486.89, representing a potential upside of about 24% from current levels. Yet the 52-week low sits at $148.25, highlighting the extreme choppiness and risk. This sets up a dramatic swing potential, with the stock having fallen over 20% in a single session and now down 14% over the past five days.

For tactical traders, the immediate setup is defined by two opposing price ceilings. The bullish analyst view provides a near-term target: JPMorgan's $510 price target and Wells Fargo's $525 target offer a clear upside ceiling if the company delivers a strong earnings beat next month. On the other side, the short thesis implies massive downside, with Gotham City Research warning of shares facing "massive downside risk." The technical breakdown below the 200-day SMA suggests the path of least resistance is lower, at least until the February 18 earnings catalyst.

The risk/reward is now highly asymmetric. The immediate risk is the stock testing the 50-day SMA and potentially the 200-day SMA, which could open a path toward the lower end of the 52-week range. The reward, if the bullish earnings thesis is validated, is a re-rating toward the $500+ range. However, given the severe allegations and the stock's recent volatility, the downside risk appears more immediate and severe. The trade hinges on the February 18 print resolving the fundamental uncertainty that technicals are now pricing in.

Catalysts and Watchpoints: What to Monitor for the Thesis

The tactical trade now hinges on a handful of specific events and metrics that will either validate the short thesis or force a re-rating of the stock. Investors must watch three key catalysts in the coming weeks.

First, the February 18 fourth-quarter earnings report is the primary event. The market is pricing in severe risk, while JPMorgan expects a "solid beat and raise". Any deviation from that bullish forecast will be a major signal. More critically, watch for any commentary on related-party transactions, loan sales, or credit support from DriveTime and Bridgecrest. The absence of such disclosures could confirm Gotham's allegations of opacity.

Second, monitor for any official response from Carvana or regulatory scrutiny. Gotham City Research explicitly warned of regulatory trouble stemming from accounting and disclosure issues. A formal rebuttal from the company, or any inquiry from the SEC, would accelerate the risk assessment. The report's prediction that Carvana's 2023 and 2024 10-Ks will need to be restated is a direct call for regulatory action. Any delay in the 2025 10-K filing, as Gotham forecasts, would be a major red flag.

Finally, track DriveTime's financial health. Gotham's entire thesis depends on the fragility of this ecosystem. The report alleges DriveTime burned over $1 billion in operating cash flow while taking on massive new debt, with leverage at 20-40x. If DriveTime's ability to provide credit support weakens further, it directly threatens Carvana's reported earnings. Any deterioration in DriveTime's cash position or interest coverage ratio will test the short's core dependency argument.

These are the watchpoints that will determine the stock's path. The February 18 print is the immediate catalyst, but the regulatory and financial health signals will provide the context to judge whether the 18% plunge was a tactical mispricing or the start of a fundamental breakdown.